Mutational and functional analysis of the SPT2 gene of Saccharomyces cerevisiae

The Saccharomyces cerevisiae SPT2 gene was identified by mutants which are suppressors of Ty and δ insertional mutations at the HIS4 locus. The ability of spt2 mutations to suppress the transcriptional interference caused by the δ promoter insertion his4-912 δ correlates with an increase in wild-t...

Full description

Bibliographic Details
Main Author: Lefebvre, Louis
Language:English
Published: 2009
Online Access:http://hdl.handle.net/2429/6958
Description
Summary:The Saccharomyces cerevisiae SPT2 gene was identified by mutants which are suppressors of Ty and δ insertional mutations at the HIS4 locus. The ability of spt2 mutations to suppress the transcriptional interference caused by the δ promoter insertion his4-912 δ correlates with an increase in wild-type HIS4 mRNA levels. The SPT2 gene is identical to SIN1, which codes for a factor genetically defined as a negative regulator of HO transcription. Mutations in SPT2/SIN1 suppress the effects of trans-acting mutations in SWI genes and of partial deletions in the C-terminal domain of the largest subunit of RNA polymerase II. Nuclear localization and protein sequence similarities suggested that the SPT2/SIN1 protein may be related to the nonhistone chromosomal protein HMG1. In order to assess the significance of this structural similarity and identify domains of SPT2 functionally important in the regulation of his4-912 δ I have studied recessive and dominant spt2 mutations created by in vitro mutagenesis. Several alleles carrying C-terminal deletions as well as point mutations in the C-terminal domain of the SPT2 protein exhibit a dominant suppressor phenotype. C-terminal basic residues necessary for wild-type SPT2 protein function which are absent from HMG1 have been identified. The competence of these mutant SPT2 proteins to interfere with the maintenance of the His⁻(Spt⁺) phenotype of a his4-912 δ strain is lost by deletion of internal HMG1-like sequences and is sensitive to the wild-type SPT2⁺ gene dosage. Using cross-reacting antipeptide polyclonal antibodies, I demonstrate that the intracellular level of the wild-type SPT2 protein is not affected in the presence of dominant mutations and furthermore that the reversion of the dominance by internal deletion of HMG1-like sequences is not mediated by altered production or stability of the mutant polypeptides. The results suggest that the products of dominant alleles directly compete with the wild-type protein. On the basis of primary sequence similarities, it is proposed that a HMG-box-like motif is required for SPT2 function in vivo and that this motif also is necessary for the dominant suppressor phenotype exhibited by some mutant SPT2 alleles.